BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2010
View Archived Issues
QTc interval is prolonged in myotonic dystrophy type 1 / News in Context
Read More
Phase II data show efficacy of Gilead Sciences' Quad anti-HIV regimen through 48 weeks
Read More
TransVax reduces cytomegalovirus viremia in phase II trial
Read More
SAR-707 reveals limitations of acyl-CoA desaturase inhibition in metabolic disorders
Read More
Chitosan-GP is efficacious in ongoing trial in patients with articular cartilage lesions
Read More
Acucela and Otsuka Pharma to codevelop and -promote OPA-6566 for glaucoma
Read More
Cylene begins phase I trial of CX-4945 in multiple myeloma
Read More
FDA grants orphan drug status for iCo-009 in visceral leishmaniasis
Read More
Phase III trial of Budesonide MMX in ulcerative colitis meets primary endpoint
Read More
Prefilled syringes of Relistor approved in U.S., E.U. and Canada
Read More
Medivation and Astellas begin phase III MDV-3100 trial in advanced prostate cancer
Read More
Astellas files for Japanese approval of darexaban for VTE prevention
Read More
Enrollment complete in phase IIa trial of XOMA-052 in type 2 diabetes
Read More
Zeria submits acotiamide for approval in Japan to treat functional dyspepsia
Read More
Unibioscreen claims novel cardiotonic steroid derivatives
Read More
Baxter obtains approval in Austria for Preflucel influenza vaccine
Read More
New voltage-gated potassium K(V)7.2/3 channel modulators described
Read More
Cleveland BioLabs reports on second safety study of CBLB-502
Read More
AstraZeneca begins enrollment in phase III OSKIRA program for fostamatinib in RA
Read More
Novel benzoxazinone derivatives claimed by NeuroSearch
Read More
Conbriza is approved in Spain for postmenopausal osteoporosis
Read More
Astellas and UMN Pharma enter definitive agreement for flu vaccines
Read More
Pieris, sanofi-aventis and Sanofi Pasteur to develop anticalin therapeutics
Read More
Astellas Pharma patents new 17-beta-HSD 5 inhibitors
Read More